{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:31:01Z","timestamp":1776285061688,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001200","name":"Australian Orthopaedic Association","doi-asserted-by":"publisher","award":["2017-123"],"award-info":[{"award-number":["2017-123"]}],"id":[{"id":"10.13039\/501100001200","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Townsville Hospital and Health Services Study, Education, Research and Training Fund","award":["2017-06"],"award-info":[{"award-number":["2017-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Dysregulated inflammatory responses are implicated in the pathogenesis of joint stiffness and arthrofibrosis following total knee arthroplasty (TKA). The purpose of this study was to compare the effects of intra-articular (IA) administration of tranexamic acid (TXA), an anti-fibrinolytic commonly used in TKA, and ALM chondroprotective solution on postoperative inflammation and joint tissue healing in a rat model of knee implant surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Male Sprague\u2013Dawley rats (<jats:italic>n<\/jats:italic>\u2009=\u200924) were randomly divided into TXA or ALM treatment groups. The right knee of each rat was implanted with titanium (femur) and polyethylene (tibia) implants. An IA bolus (0.1\u00a0ml) of TXA or ALM was administered after implantation and capsule closure, and before skin closure. Postoperative coagulopathy, haematology and systemic inflammatory changes were assessed. Inflammatory and fibrotic markers were assessed in joint tissue, 28\u00a0days after surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Haemostasis was comparable in animals treated with TXA or ALM after knee implant surgery. In contrast to ALM-treated animals, systemic inflammatory markers remained elevated at day 5 (IL-6, IL-12, IL-10, platelet count) and day 28 (IL-1\u03b2, IL-10) following surgery in TXA-treated animals. At day 28 following surgery, the extension range of motion of operated knees was 1.7-fold higher for ALM-treated animals compared to the TXA group. Key inflammatory mediators (NF-\u03baB, IL-12, IL-2), immune cell infiltration (CD68<jats:sup>+<\/jats:sup>cells) and markers of fibrosis (\u03b1-SMA, TGF-\u03b2) were also lower in capsular tissue of ALM-treated knees at day 28.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Data suggest that IA administration of ALM is superior to TXA for reducing postoperative systemic and joint inflammation and promoting restoration of healthy joint tissue architecture in a rat model of TKA. Further studies are warranted to assess the clinical translational potential of ALM IA solution to improve patient outcomes following arthroplasty.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13018-021-02871-y","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T10:03:12Z","timestamp":1639994592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4795-5539","authenticated-orcid":false,"given":"Jodie L.","family":"Morris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley L.","family":"Letson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Biros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Dlaska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushik","family":"Hazratwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey P.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"2871_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3899\/jrheum.170990","volume":"46","author":"JA Singh","year":"2019","unstructured":"Singh JA, Yu S, Chen L, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020\u20132040 using the National Inpatient Sample. J Rheumatol. 2019;46:1134\u201340. https:\/\/doi.org\/10.3899\/jrheum.170990.","journal-title":"J Rheumatol"},{"key":"2871_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ocl.2019.02.005","volume":"50","author":"R Thompson","year":"2019","unstructured":"Thompson R, Novikov D, Cizmic Z, Feng JE, Fideler K, Sayeed Z, et al. Arthrofibrosis after total knee arthroplasty: pathophysiology, diagnosis, and management. Orthop Clin North Am. 2019;50:269\u201379. https:\/\/doi.org\/10.1016\/j.ocl.2019.02.005.","journal-title":"Orthop Clin North Am"},{"key":"2871_CR3","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2106\/JBJS.18.01217","volume":"101","author":"ME Tibbo","year":"2019","unstructured":"Tibbo ME, Limberg AK, Salib CG, Ahmed AT, Wijnen AJ, Berry DJ, et al. Acquired idiopathic stiffness after total knee arthroplasty: a systematic review and meta-analysis. J Bone Jt Surg Am. 2019;101:1320\u201330. https:\/\/doi.org\/10.2106\/JBJS.18.01217.","journal-title":"J Bone Jt Surg Am"},{"issue":"6","key":"2871_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.arth.2020.02.046","volume":"35","author":"MA Malahias","year":"2020","unstructured":"Malahias MA, Birch GA, Zhong H, Sideris A, Gonzalez Della Valle A, Sculco PK, et al. Postoperative serum cytokine levels are associated with early stiffness after total knee arthroplasty: a prospective cohort study. J Arthroplasty. 2020;35(6):336\u201347. https:\/\/doi.org\/10.1016\/j.arth.2020.02.046.","journal-title":"J Arthroplasty"},{"key":"2871_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.610131","author":"GP Dobson","year":"2021","unstructured":"Dobson GP, Biros E, Letson HL, Morris JM. Living in a hostile world: inflammation, new drug development, and coronavirus. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2020.610131.","journal-title":"Front Immunol"},{"key":"2871_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3978\/j.issn.2305-5839.2015.01.25","volume":"3","author":"T Danninger","year":"2015","unstructured":"Danninger T, Memtsoudis SG. Tranexamic acid and orthopedic surgery-the search for the holy grail of blood conservation. Ann Transl Med. 2015;3:77. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.01.25.","journal-title":"Ann Transl Med"},{"key":"2871_CR7","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.arth.2018.08.002","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Bini SA, Clarke HD, et al. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2018;33:3065\u20139. https:\/\/doi.org\/10.1016\/j.arth.2018.08.002.","journal-title":"J Arthroplasty"},{"key":"2871_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.32098\/mltj.02.2021.18","volume":"11","author":"V La Banca","year":"2021","unstructured":"La Banca V, Suzuki Leal Roque JG, Protta T, Schmidt Navarro M. Evaluation of antifibrinolytic use in anterior cruciate ligament arthroscopic reconstruction: a prospective clinical trial. Muscles Ligaments Tendons J. 2021;11:340\u20133. https:\/\/doi.org\/10.32098\/mltj.02.2021.18.","journal-title":"Muscles Ligaments Tendons J"},{"key":"2871_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2106\/JBJS.17.00908","volume":"100","author":"MP Abdel","year":"2018","unstructured":"Abdel MP, Chalmers BP, Taunton MJ, Pagnano MW, Trousdale RT, Sierra RJ, et al. Intravenous versus topical tranexamic acid in total knee arthroplasty: both effective in a randomized clinical trial of 640 patients. J Bone Jt Surg Am. 2018;100:1023\u20139. https:\/\/doi.org\/10.2106\/JBJS.17.00908.","journal-title":"J Bone Jt Surg Am"},{"key":"2871_CR10","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.arth.2017.02.068","volume":"32","author":"HA Demos","year":"2017","unstructured":"Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr. Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. J Arthroplasty. 2017;32:2375\u201380. https:\/\/doi.org\/10.1016\/j.arth.2017.02.068.","journal-title":"J Arthroplasty"},{"key":"2871_CR11","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1177\/0363546515599629","volume":"43","author":"K Karaaslan","year":"2015","unstructured":"Karaaslan K, Karao\u011flu S, Yurdakul E. Reducing intra-articular hemarthrosis after arthroscopic anterior cruciate ligament reconstruction by the administration of intravenous tranexamic acid: a prospective, randomized controlled trial. Am J Sports Med. 2015;43:2720\u20136. https:\/\/doi.org\/10.1177\/0363546515599629.","journal-title":"Am J Sports Med"},{"key":"2871_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0037-1600092","volume":"31","author":"JT Moskal","year":"2018","unstructured":"Moskal JT, Capps SG. Intra-articular tranexamic acid in primary total knee arthroplasty: meta-analysis. J Knee Surg. 2018;31:56\u201367. https:\/\/doi.org\/10.1055\/s-0037-1600092.","journal-title":"J Knee Surg"},{"key":"2871_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12891-019-2715-9","volume":"20","author":"E Tille","year":"2019","unstructured":"Tille E, Mysliwietz J, Beyer F, Postler A, L\u00fctzner J. Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty. BMC Musculosk Disord. 2019;20:341. https:\/\/doi.org\/10.1186\/s12891-019-2715-9.","journal-title":"BMC Musculosk Disord"},{"key":"2871_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.arth.2016.07.004","volume":"32","author":"N Goyal","year":"2017","unstructured":"Goyal N, Chen DB, Harris IA, Rowden NJ, Kirsh G, MacDessi SJ. Intravenous vs intra-articular tranexamic acid in total knee arthroplasty: a randomized, double-blind trial. J Arthroplasty. 2017;32:28\u201332. https:\/\/doi.org\/10.1016\/j.arth.2016.07.004.","journal-title":"J Arthroplasty"},{"key":"2871_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13018-018-0855-5","volume":"13","author":"AL Grant","year":"2018","unstructured":"Grant AL, Letson HL, Morris JL, McEwen P, Hazratwala K, Wilkinson M, et al. Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study. J Orthop Surg Res. 2018;13:149. https:\/\/doi.org\/10.1186\/s13018-018-0855-5.","journal-title":"J Orthop Surg Res"},{"key":"2871_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/230949901402200205","volume":"22","author":"B Jang","year":"2014","unstructured":"Jang B, Kao M, Bohm MT, Harris IA, Chen DB, MacDessi SJ. Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty. J Orthop Surg (Hong Kong). 2014;22:146\u20139. https:\/\/doi.org\/10.1177\/230949901402200205.","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"2871_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1302\/0301-620X.100B3.BJJ-2017-1135.R1","volume":"100","author":"JD Parker","year":"2018","unstructured":"Parker JD, Lim KS, Kieser DC, Woodfield TBF, Hooper GJ. Is tranexamic acid toxic to articular cartilage when administered topically? What is the safe dose? Bone Joint J. 2018;100:404\u201312. https:\/\/doi.org\/10.1302\/0301-620X.100B3.BJJ-2017-1135.R1.","journal-title":"Bone Joint J"},{"key":"2871_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-020-06219-7","author":"SM Bolam","year":"2020","unstructured":"Bolam SM, O\u2019Regan-Brown A, Monk AP, Musson DS, Cornish J, Munro JT. Toxicity of tranexamic acid (TXA) to intra-articular tissue in orthopaedic surgery: a scoping review. Knee Surg Sports Traumatol Arthrosc. 2020. https:\/\/doi.org\/10.1007\/s00167-020-06219-7.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2871_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1302\/2046-3758.81.BJR-2018-0181.R1","volume":"8","author":"M McLean","year":"2019","unstructured":"McLean M, McCall K, Smith IDM, Blyth M, Kitson SM, Crowe LAN, et al. Tranexamic acid toxicity in human periarticular tissues. Bone Joint Res. 2019;8:11\u20138. https:\/\/doi.org\/10.1302\/2046-3758.81.BJR-2018-0181.R1.","journal-title":"Bone Joint Res"},{"key":"2871_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/1753425917718921","volume":"23","author":"L Davenport","year":"2017","unstructured":"Davenport L, Letson HL, Dobson GP. Immune-inflammatory activation after a single laparotomy in a rat model: effect of adenosine, lidocaine and Mg2+ infusion to dampen the stress response. Innate Immun. 2017;23:482\u201394. https:\/\/doi.org\/10.1177\/1753425917718921.","journal-title":"Innate Immun"},{"key":"2871_CR21","unstructured":"Dobson GP, Letson HL. Technical report: a new ultra-small volume fluid for far-forward, non-compressible hemorrhage and traumatic brain injury. Fort Detrick, Maryland; 2016. https:\/\/apps.dtic.mil\/sti\/citations\/AD1007400."},{"key":"2871_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijsu.2020.07.017","volume":"81","author":"GP Dobson","year":"2020","unstructured":"Dobson GP. Trauma of major surgery: a global problem that is not going away. Int J Surg. 2020;81:47\u201354. https:\/\/doi.org\/10.1016\/j.ijsu.2020.07.017.","journal-title":"Int J Surg"},{"key":"2871_CR23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.55460\/06VT-9IH4","volume":"20","author":"GP Dobson","year":"2020","unstructured":"Dobson GP, Letson HL. Far forward gaps in hemorrhagic shock and prolonged field care: an update of ALM fluid therapy for field use. J Spec Oper Med. 2020;20:128\u201334.","journal-title":"J Spec Oper Med"},{"key":"2871_CR24","doi-asserted-by":"publisher","first-page":"e0188144","DOI":"10.1371\/journal.pone.0188144","volume":"12","author":"HL Letson","year":"2017","unstructured":"Letson HL, Dobson GP. Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage. PLoS ONE. 2017;12:e0188144. https:\/\/doi.org\/10.1371\/journal.pone.0188144.","journal-title":"PLoS ONE"},{"key":"2871_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/TA.0000000000001454","volume":"82","author":"HL Letson","year":"2017","unstructured":"Letson HL, Dobson GP. 3% NaCl adenosine, lidocaine, Mg2+ (ALM) bolus and 4 hours \u201cdrip\u201d infusion reduces noncompressible hemorrhage by 60% in a rat model. J Trauma Acute Care Surg. 2017;82:1063\u201372. https:\/\/doi.org\/10.1097\/TA.0000000000001454.","journal-title":"J Trauma Acute Care Surg"},{"key":"2871_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/TA.0000000000002397","volume":"87","author":"HL Letson","year":"2019","unstructured":"Letson HL, Morris JL, Biros E, Dobson GP. Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: A model for studying differential gene expression and extending biological time. J Trauma Acute Care Surg. 2019;87:606\u201313. https:\/\/doi.org\/10.1097\/TA.0000000000002397.","journal-title":"J Trauma Acute Care Surg"},{"key":"2871_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40634-019-0185-5","volume":"6","author":"A McCutchan","year":"2019","unstructured":"McCutchan A, Dobson GP, Stewart N, Letson HL, Grant AL, Jovanovic IA, et al. Absence of cytotoxic and inflammatory effects following in vitro exposure of chondrogenically-differentiated human mesenchymal stem cells to adenosine, lidocaine and Mg2+ solution. J Exper Orthop. 2019;6:16. https:\/\/doi.org\/10.1186\/s40634-019-0185-5.","journal-title":"J Exper Orthop"},{"key":"2871_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s41231-021-00084-3","author":"JL Morris","year":"2021","unstructured":"Morris JL, Letson HL, McEwen P, Biros E, Dlaska C, Hazratwala K, et al. Intra-articular adenosine, lidocaine and magnesium (ALM) solution decreases postoperative joint fibrosis in an experimental knee implant model. Transl Med Commun. 2021. https:\/\/doi.org\/10.1186\/s41231-021-00084-3.","journal-title":"Transl Med Commun"},{"key":"2871_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/TA.0000000000000881","volume":"80","author":"GP Dobson","year":"2016","unstructured":"Dobson GP, Letson HL. Adenosine, lidocaine, and Mg2+ (ALM): From cardiac surgery to combat casualty care\u2014teaching old drugs new tricks. J Trauma Acute Care Surg. 2016;80:135\u201345. https:\/\/doi.org\/10.1097\/TA.0000000000000881.","journal-title":"J Trauma Acute Care Surg"},{"key":"2871_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-0039-1701018","volume":"46","author":"GP Dobson","year":"2020","unstructured":"Dobson GP, Morris JL, Davenport L, Letson HL. Traumatic-induced coagulopathy as a systems failure: a new window into hemostasis. Semin Thromb Hemost. 2020;46:199\u2013214. https:\/\/doi.org\/10.1055\/s-0039-1701018.","journal-title":"Semin Thromb Hemost"},{"key":"2871_CR31","doi-asserted-by":"publisher","first-page":"bio045203","DOI":"10.1242\/bio.045203","volume":"8","author":"JL Morris","year":"2019","unstructured":"Morris JL, Letson HL, Grant A, Wilkinson M, Hazratwala K, McEwen P. Experimental model of peri-prosthetic infection of the knee caused by Staphylococcus aureus using biomaterials representative of modern TKA. Biol Open. 2019;8:bio045203. https:\/\/doi.org\/10.1242\/bio.045203.","journal-title":"Biol Open"},{"key":"2871_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1042\/BSR20160460","volume":"37","author":"ZY Gao","year":"2017","unstructured":"Gao ZY, Wu JX, Liu WB, Sun JK. Reduction of adhesion formation after knee surgery in a rat model by botulinum toxin A. Biosci Rep. 2017;37:60. https:\/\/doi.org\/10.1042\/BSR20160460.","journal-title":"Biosci Rep"},{"key":"2871_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13018-020-1544-8","volume":"15","author":"A Bernstein","year":"2020","unstructured":"Bernstein A, Reichert SNA, S\u00fcdkamp NP, Hernandez SL, Nerlich AG, K\u00fchle J, et al. Expression of xylosyltransferases I and II and their role in the pathogenesis of arthrofibrosis. J Orthop Surg Res. 2020;15:27. https:\/\/doi.org\/10.1186\/s13018-020-1544-8.","journal-title":"J Orthop Surg Res"},{"key":"2871_CR34","doi-asserted-by":"publisher","first-page":"12537","DOI":"10.1038\/srep12537","volume":"5","author":"I Faust","year":"2015","unstructured":"Faust I, Traut P, Nolting F, Petschallies J, Neumann E, Kunisch E, et al. Human xylosyltransferases\u2014mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapy. Sci Rep. 2015;5:12537. https:\/\/doi.org\/10.1038\/srep12537.","journal-title":"Sci Rep"},{"issue":"Suppl","key":"2871_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.joca.2010.05.030","volume":"18","author":"N Gerwin","year":"2010","unstructured":"Gerwin N, Bendele AM, Glasson S, Carlson CS. The OARSI histopathology initiative\u2014recommendations for histological assessments of osteoarthritis in the rat. Osteoarthr Cartil. 2010;18(Suppl):24\u201334. https:\/\/doi.org\/10.1016\/j.joca.2010.05.030.","journal-title":"Osteoarthr Cartil"},{"key":"2871_CR36","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1016\/j.arthro.2019.09.007","volume":"35","author":"MG Siegel","year":"2019","unstructured":"Siegel MG. The dangers and concerns of intra-articular tranexamic acid. Arthrosc. 2019;35:2973\u20134. https:\/\/doi.org\/10.1016\/j.arthro.2019.09.007.","journal-title":"Arthrosc"},{"key":"2871_CR37","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2106\/JBJS.19.00258","volume":"101","author":"KM Jules-Elysee","year":"2019","unstructured":"Jules-Elysee KM, Tseng A, Sculco TP, Baaklini LR, McLawhorn AS, Pickard AJ, et al. Comparison of topical and intravenous tranexamic acid for total knee replacement: a randomized double-blinded controlled study of effects on tranexamic acid levels and thrombogenic and inflammatory marker levels. J Bone Joint Surg Am. 2019;101:2120\u20138. https:\/\/doi.org\/10.2106\/JBJS.19.00258.","journal-title":"J Bone Joint Surg Am"},{"key":"2871_CR38","first-page":"e497","volume":"44","author":"JR Tuttle","year":"2015","unstructured":"Tuttle JR, Feltman PR, Ritterman SA, Ehrlich MG. Effects of tranexamic acid cytotoxicity on in vitro chondrocytes. Am J Orthop (Belle Mead NJ). 2015;44:e497-502.","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"2871_CR39","doi-asserted-by":"publisher","first-page":"e17229","DOI":"10.1371\/journal.pone.0017229","volume":"6","author":"CA Reichel","year":"2011","unstructured":"Reichel CA, Lerchenberger M, Uhl B, Rehberg M, Berberich N, Zahler S, et al. Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature. PLoS ONE. 2011;6:e17229. https:\/\/doi.org\/10.1371\/journal.pone.0017229.","journal-title":"PLoS ONE"},{"key":"2871_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood.2018874859","volume":"134","author":"LM Silva","year":"2019","unstructured":"Silva LM, Lum AG, Tran C, Shaw MW, Gao Z, Flick MJ, et al. Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation. Blood. 2019;134:291\u2013303. https:\/\/doi.org\/10.1182\/blood.2018874859.","journal-title":"Blood"},{"key":"2871_CR41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1113\/jphysiol.2011.225417","volume":"590","author":"KY Stokes","year":"2012","unstructured":"Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol. 2012;590:1023\u201334. https:\/\/doi.org\/10.1113\/jphysiol.2011.225417.","journal-title":"J Physiol"},{"key":"2871_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/TA.0000000000002092","volume":"86","author":"CD Barrett","year":"2019","unstructured":"Barrett CD, Moore HB, Kong YW, Chapman MP, Sriram G, Lim D, et al. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator\u2013dependent manner. J Trauma Acute Care Surg. 2019;86:101\u20137. https:\/\/doi.org\/10.1097\/TA.0000000000002092.","journal-title":"J Trauma Acute Care Surg"},{"key":"2871_CR43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s001670100218","volume":"9","author":"U Bosch","year":"2001","unstructured":"Bosch U, Zeichen J, Skutek M, Haeder L, van Griensven M. Arthrofibrosis is the result of a T cell mediated immune response. Knee Surg Sports Traumatol Arthrosc. 2001;9:282\u20139. https:\/\/doi.org\/10.1007\/s001670100218.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2871_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41413-019-0047-x","volume":"7","author":"KM Usher","year":"2019","unstructured":"Usher KM, Zhu S, Mavropalias G, Carrino JA, Zhao J, Xu J. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res. 2019;7:9. https:\/\/doi.org\/10.1038\/s41413-019-0047-x.","journal-title":"Bone Res"},{"issue":"8","key":"2871_CR45","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.joca.2017.03.008","volume":"25","author":"A Langkilde","year":"2017","unstructured":"Langkilde A, Jakobsen TL, Bandholm TQ, Eugen-Olsen J, Blauenfeldt T, Petersen J, et al. Inflammation and post-operative recovery in patients undergoing total knee arthroplasty-secondary analysis of a randomized controlled trial. Osteoarthr Cartil. 2017;25(8):1265\u201373. https:\/\/doi.org\/10.1016\/j.joca.2017.03.008.","journal-title":"Osteoarthr Cartil"},{"key":"2871_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12891-017-1597-y","volume":"18","author":"HB Si","year":"2017","unstructured":"Si HB, Yang TM, Zeng Y, Zhou ZK, Pei FX, Lu YR, et al. Correlations between inflammatory cytokines, muscle damage markers and acute postoperative pain following primary total knee arthroplasty. BMC Musculoskelet Disord. 2017;18:265. https:\/\/doi.org\/10.1186\/s12891-017-1597-y.","journal-title":"BMC Musculoskelet Disord"},{"key":"2871_CR47","first-page":"1","volume":"122","author":"CD Fryar","year":"2018","unstructured":"Fryar CD, Kruszon-Moran D, Gu Q, Ogden CL. Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999\u20132000 through 2015\u20132016. Natl Health Stat Rep. 2018;122:1\u201316.","journal-title":"Natl Health Stat Rep"},{"key":"2871_CR48","doi-asserted-by":"publisher","first-page":"16469","DOI":"10.1038\/srep16469","volume":"5","author":"N Abdul","year":"2015","unstructured":"Abdul N, Dixon D, Walker A, Horabin J, Smith N, Weir DJ, et al. Fibrosis is a common outcome following total knee arthroplasty. Sci Rep. 2015;5:16469. https:\/\/doi.org\/10.1038\/srep16469.","journal-title":"Sci Rep"},{"key":"2871_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/03008207.2018.1517759","volume":"60","author":"AF Chen","year":"2019","unstructured":"Chen AF, Lee YS, Seidl AJ, Abboud JA. Arthrofibrosis and large joint scarring. Connect Tissue Res. 2019;60:21\u20138. https:\/\/doi.org\/10.1080\/03008207.2018.1517759.","journal-title":"Connect Tissue Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02871-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-021-02871-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02871-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:19:13Z","timestamp":1674112753000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-021-02871-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2871"],"URL":"https:\/\/doi.org\/10.1186\/s13018-021-02871-y","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was approved by the Institutional Animal Ethics Committee (approval no. A2487) and conducted in accordance with the ARRIVE and NHMRC guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GPD is the sole inventor of the ALM concept for cardioplegia and trauma, but has no financial interests in any entity or business. All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"726"}}